2005 Edition Report on Drug Administration Procedure & Practices ...

More documents

Recommendations

Info

DISPOSAL OF HOSPITAL PHARMACEUTICAL CHEMCIAL WASTES1. Scope of Service1.1. The service covers the collection and disposal of the following categories ofunwanted materials;a. Antibiotics (as defined in Antibiotics Ordinance, Cap. 137);b. Dangerous Drugs (as defined in Dangerous Drugs Ordinance, Cap. 134);c. Poisons (as defined in Pharmacy and Poisons Ordinance, Cap. 138);d. Other pharmaceutical products and medicines, not elsewhere specified.2. Containers & Labels2.1 Solidsa. Wide mouth screw open top 20 Litre HDPE pails will be provided byEnviropace for collection of : (i) tablets, capsules with and without packing,and other totally solid materials, (ii) vials and ampoules containing liquids orslurries not exceeding 50ml each.b. Wastes should be filled to occupy maximum 70% of the volume of the pails(i.e. maximum 14 litres/pail). Liquid content in each container should notexceed 500 ml in total. A Liquid Waste Tracking Label (See Appendix 1)will be attached to the pail at time of despatching. The slip is to be updatedeach time when liquid waste is disposed into the pail.c. Please refer to Appendix IIA for the design of the solid pharmaceutical wastecontainer label.2.2 Liquids3. Collection Plana. Closed top screw cap 20 litre HDPE pail will be provided for collection ofwastes other than those described in Item 2.1 above, e.g. bottles containingmore than 50ml of liquid.b. All wastes should be decanted from original packing into the collection pail.In case there are reactions during decanting, stop the process and report toEnviropace, Miss Dandy Wong at 2434 6450. Instructions on handling andsafety precautions would be provided.c. Please refer to Appendix IIB for the design of the liquid pharmaceuticalwaste container label.d. Emptied containers properly rinsed with water are not considered aschemical wastes and can be discarded as ordinary refuse.3.1 One open top container for solids and one closed top container for liquids will bedispatched to each hospital, upon their request, for pharmaceutical wastes.Additional containers will be provided on a case by case basis.1
3.2 Collection of pharmaceutical wastes will be scheduled at time of collection ofother chemical wastes from hospitals.3.3 The Chemical Waste Service Co-ordinator appointed by each hospital, should takecharge of co-ordination of this service.4. Documentation of Part A Chemical Waste4.1 On disposal of materials categorized under Item 1.1a to 1.1c above, wasteproducers are required by law to notify EPD prior to disposal using Form EPD-132. In such case Enviropace would arrange collection service only upon receiptof copy of EPD’s Part A Waste disposal directions on Form EPD-131 specifyingthe CWTF as the designated disposal point.4.2 A Part A Waste Verification Label (Appendix III) will be attached to eachcontainer at time of dispatching. If the container contains Part A waste at time ofcollection, a packing list must accompany the container. If the container does notcontain any Part A waste, the Chemical Waste Service Co-ordinator or anappropriate designated person in charge shall sign next to the confirmationstatement to verify (Appendix III).4.3 Form EPD-132 should be sent to :Environmental Protection DeptWaste & Waster Management Group25/F, Southorn Centre130 Hennessy RoadWan ChaiHong KongEnquiry Hotline : 2835 1082Fax : 2305 0453[Appendix I, IIA, IIB, III are not included]HAHO Sept 95(revised in Jan 05)2
Page 2 and 3:
ForewordMedication safety and provi
Page 4 and 5:
Chapter 6 summarizes the specific r
Page 6 and 7:
Chapter 6Conclusions and Recommenda
Page 8 and 9:
CHAPTER ONETHE WORKING GROUPMEMBERS
Page 10 and 11:
CHAPTER TWOTHE PROGRESS REPORT2.1 P
Page 12 and 13:
CHAPTER THREEAREAS FOR IMPROVEMENT
Page 14 and 15:
Existing In-patient Drug Administra
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
CHAPTER FOURRECOMMENDED PRACTICES A
Page 24 and 25:
Drug Name4.11 There should be a hos
Page 26 and 27:
Electronic prescribing (Medication
Page 28 and 29:
4.46 When the use of CM is permitte
Page 30 and 31:
cytotoxic and central intravenous a
Page 32 and 33:
4.72 Special precautions should be
Page 34 and 35:
4.84 To prevent mixing up medicatio
Page 36 and 37:
The Principle of Three checks and F
Page 38 and 39:
4.111 Three-way (red and blue) and
Page 40 and 41:
or their discharge or death, should
Page 42 and 43:
operational requirement but also it
Page 44 and 45: Quality Complaints on Pharmaceutica
Page 46 and 47: LEVELSHAHOCE / DTOOLS & MECHANISMDU
Page 48 and 49: Medication Incident Report<
Page 50 and 51: Continuing Education6.18 In order t
Page 52 and 53: APPENDICESAppendix 1Appendix 2Appen
Page 54 and 55: Hospital Authority Hospital No. : I
Page 56 and 57: Sensitivity:Prescription/ routewith
Page 58 and 59: Appendix 3aLists of HA-wide Approve
Page 60 and 61: DRUGTeniposideABBREVIATIONVM-26Thia
Page 62 and 63: Appendix 3b“Do Not Use Abbreviati
Page 64 and 65: Appendix 4Schedule for the Administ
Page 66 and 67: Appendix 5Mechanism for the Managem
Page 68 and 69: 4. As with all medications, there s
Page 70 and 71: Appendix 6HA Guideline on Safe Mana
Page 72 and 73: 2.1 Concentrated potassium chloride
Page 74 and 75: Appendix 7Supply of Antidotes and D
Page 76 and 77: 複本 Antidotes and emeg drug lis
Page 78 and 79: Appendix 8Guidelines for Supply of
Page 80 and 81: substitution with other drugs in ac
Page 82 and 83: Appendix 9Samples of the Line Label
Page 84 and 85: Appendix 10Guidelines on the use of
Page 86 and 87: Appendix 11Guidelines on Patient Se
Page 88 and 89: Operational Guidelines7. The operat
Page 90 and 91: COC(N) Paper 12/2004Approved by COC
Page 92 and 93: 7.4 Evaluation Record and report th
Page 96 and 97: Appendix 14Guidelines on the Handli
Page 98 and 99: Appendix 15Medication Incident <str
Page 100 and 101: Hospital Authority Medication Incid
Page 102 and 103: QUALITY ASSURANCE IN DRUG THERAPYHO
Page 104 and 105: Fig. 1: ADR voluntary reporting sys
Page 106 and 107: PROCEUDRE FOR QUALITY COMPLAINTSONP
Page 108: Part II Procurement Section, CPO1.
show all

2005 Edition Report on Drug Administration Procedure & Practices ...

Create successful ePaper yourself

Delete template?

Save as template?